This is an old revision of the document!
COVID-19 Vaccine Associated Myopericarditis
Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Lymphadenopathy
Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents
Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age
Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents
Insights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis: could accidental intravenous injection of a vaccine induce myopericarditis
Acute myocarditis after administration of BNT162b2 vaccine against COVID-19
Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis
COVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis.
Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model
Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report
Report of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male
Myopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents
Acute myopericarditis after COVID-19 vaccine in adolescents
Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e28. doi:10.1097/INF.0000000000003389
.
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-320. doi:10.1016/j.jpeds.2021.06.083
mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. J Pediatr. doi:10.1016/j.jpeds.2021.12.025.
[[https://www.ncbi.nlm.nih.gov/pubmed/34332972|Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, 5. doi:10.1016/j.jpeds.2021.07.057
Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report. Acad Emerg Med, 28(8), 918-921. doi:10.1111/acem.14322
Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC Open. doi:10.1016/j.cjco.2021.12.002
Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019
Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report
